Physician profile
Rex A Marco
NPI 1205861887
$174,397.47
in general payments reported to CMS, 2019-2025
15 companies · $5,257 in 2025
The $5,257 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43K · 2020: $9,904 · 2021: $3,146 · 2022: $74K · 2023: $34K · 2024: $5,433 · 2025: $5,257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $27K · Royalty Or License: $10K · Food and Beverage: $5,082 · Travel and Lodging: $2,683.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $26,755.00 |
| Royalty Or License | $10,094.84 |
| Food and Beverage | $5,081.63 |
| Travel and Lodging | $2,682.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $49,111.91 | 2019-2024 | |
| Depuy Synthes Sales INC. | $33,111.51 | 2019-2025 | Expedium, Symphony, Viper |
| Stryker Corporation | $26,688.86 | 2019-2024 | Airo, Mesa Spinal System, Everest Spinal System |
| Nuvasive, INC. | $23,475.73 | 2019-2022 | |
| Cerapedics INC. | $21,213.90 | 2022-2023 | I-Factor Peptide Enhanced Bone Graft |
| Globus Medical, INC. | $18,059.15 | 2019-2025 | Colosseum, Mesh, Colosseum |
| Medtronic, INC. | $1,266.54 | 2022-2025 | Mazor X System, Unid_pass |
| Alphatec Spine, INC | $576.27 | 2022-2025 | Other - Miscellaneous |
| Si-Bone, INC. | $292.08 | 2023-2025 | |
| Medtronic USA, INC. | $139.28 | 2020 | |
| Heron Therapeutics, INC. | $124.08 | 2024 | Zynrelef |
| Kuros Biosciences USA, INC | $123.69 | 2023 | |
| Wound Management Technologies, INC | $80.75 | 2019 | |
| Carlsmed, INC. | $74.65 | 2024 | Aprevo |
| Pacira Pharmaceuticals Incorporated | $59.07 | 2023 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rex Marco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.